TLDR Low-dose oral minoxidil is effective and safe for treating androgenetic alopecia.
This study evaluates the efficacy and safety of low-dose oral minoxidil (LDOM) in treating androgenetic alopecia (AGA) and AGA unmasked by telogen effluvium. The findings demonstrate that LDOM is both effective and safe for patients in both groups, with comparable results. This supports the use of LDOM as a reliable treatment option for AGA, potentially enhancing patient outcomes and quality of life.
July 2023 in “JAAD International” Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.
17 citations,
November 2021 in “Journal of Cosmetic Dermatology” 
39 citations,
June 2021 in “Journal of The American Academy of Dermatology” Low-dose oral minoxidil safely treats hair loss, with hypertrichosis as main side effect.
80 citations,
December 2017 in “International Journal of Dermatology” Low-dose oral minoxidil and spironolactone combo effectively reduces hair loss and improves hair density in women.
14 citations,
April 2016 in “International Journal of Trichology”
February 2024 in “Cosmoderma” Low-dose oral minoxidil can help treat male and female pattern hair loss, especially in those who can't use topical treatments or have heart health issues.
May 2015 in “Journal of The American Academy of Dermatology” 5% minoxidil foam helps women with thinning hair.
8 citations,
November 2014 in “PubMed” April 2011 in “The FASEB Journal” 
1 citations,
September 2002 in “PubMed” Minoxidil helps stimulate hair growth and reduce hair loss in women with androgenic alopecia.
127 citations,
July 1996 in “Journal of The American Academy of Dermatology” Minoxidil shortens baldness from chemotherapy by 50.2 days without significant side effects.
